This paper describes uses and limits of both empirical data and predictive exposure models in assessing lead exposure; it was prepared as part of the proceedings for a U.S. Environmental Protection Agency (U.S. EPA) meeting on lead biokinetic models. The earlier portion is more concise and summarizing, owing to the huge amount of data. Some later sections are of necessity more detailed because of the evolving nature of the topics and their importance, their current stage of development, and need for a current assessment. Critical current assessment is particularly required for the topic of lead bioavailability, a significant element in reliable lead exposure measurement and modeling. Lead bioavailability in its many multidisciplinary complexities and nuances is still poorly understood and misunderstood by many, is interpretively misused by others, and continues to feed a growing, increasingly jumbled literature. These differing tasks involve different styles of writing on the respective topics, differences the reader hopefully will not find too abrupt in flow of thought and information.
Lead exposure in this paper refers to both the amount of lead entering various receiving compartments of the body through inhalation and ingestion, and the subsequent absorption of some fraction of the lead intake. Intake is sometimes defined by others as exposure, whereas the amount absorbed is defined as dose. There are several ways one can attempt to quantitate lead exposure in humans. One can measure the amount of lead in biologic media from these subjects or lead in environmental media from their surroundings. One can also estimate, i.e., predict, the extent of lead exposure using a mathematical model and available environmental lead or exposure information, e.g., biologic data, for input.
As noted by Mushak (1) , models are abstract constructions and depictions of complex systems that permit easier comprehension for study and application. Biokinetic models of substance uptake, disposition, and removal are the subject of regulatory and health policy interest and increasingly figure in risk assessment practices, per the guidelines of the National Research Council (NRC) (2) . The guidelines are categorized as hazard identification, dose-response relationships, exposure assessment, and risk characterization. The first two are typically general or generic; the remaining two are case-or site-specific. In the case of lead, the first two components are relatively well studied, but it is the site-specific lead exposures that often drive the utility of the overall paradigm. Modeling of lead exposure in human populations is especially useful in those situations where there are limits on field measurements of lead exposure.
Models of human lead exposure are of various categorical and computational types and they differ in their relative complexity and range of application. The earliest are purely ad hoc models based on specific datasets in the form of equations derived from regression analyses. These involve predicting a dependent measure, such as blood lead concentration, when regressed against an environmental measure such as soil or dust lead concentrations. These statistically defined models integrate measured data into an inferential statement about the relationship of lead in some medium to some measure of body lead burden, e.g., lead in blood (PbB). We infer some overall relationship but cannot delineate the mechanisms by which that relationship operates physiologically, anatomically, or biochemically. Descriptively, these models are crosssectional in nature and assume that the depiction of lead's behavior represents steady-state conditions. An example of an ad hoc statistical model based on regression data is that of Angle et al. (3) linking child PbB to urban environmental lead data.
Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998 A relatively more sophisticated form of (multiple) regression analysis, structural equation modeling, represents a pathway approach in which specifics of the pathways by which environmental lead sources provide lead to human intake and uptake can be ascertained to some extent. Here, we can fill in some of the intermediate, external steps between a lead source such as airborne lead or lead paint and eventual lead uptake.
The predictive value of statistical, regression-based models is often limited to the particular set of conditions prevailing in the study producing the model. The more complex and widely applicable model approach is the physiologic mechanistic model, where one constructs as accurately as feasible a quantitative, mathematical simulation of what happens when there is lead intake and uptake. This simulation assumes biokinetic mechanisms of lead behavior in vivo. Historically, these models have conceptually and computationally consisted of the earlier classical compartment models, the more recent physiologically based pharmacokinetic (PBPK) model, and hybrids of the two. The latter include the U.S. EPA's integrated exposure uptake biokinetic (IEUBK) model for childhood lead exposure (4-7), the variable-age Leggett model (8) and the O'Flaherty PBPK model (9, 10) . These biokinetic mathematical models have focused on blood lead as the predictive internal exposure marker. The IEUBK model is a particular focus of this paper. Use of empirical data in lead exposure assessment can take several forms: measurements in a research study, preliminary data collection to establish more systematic measurements, and lead exposure monitoring frameworks through serial, systematic measurements. These especially apply for PbB data collection.
Uses and Limits of Empirical
With reference to the utility and limits of empirical data in exposure model assessment, the accuracy and validity of empirical data used for calibrating or Although air or groundwater lead measurements may be done in some systematic monitoring framework, a number of other lead-containing media of interest at some particular site are more commonly examined on a single or limited repeat sampling basis. This would typically be the case for soil, dust, and paint samples.
The environmental media sampling design for subsequent lead measurements can often be the largest source of uncertainty and variability in arriving at most exposure-representative statistical depictions of environmental lead contamination. These include the "what" and the "how" of media lead sampling. This is best illustrated in the first instance by the question, What does one collect for lead measurement in the way of environmental sampling? This will be a difficult question to answer when there is lack of understanding or information about what the sources and pathways of lead are to the subjects under study. Lead readily undergoes environmental cycling into and out of environmental compartments that may also serve as exposure media for humans.
The complexity and interrelationships among these compartments for lead are presented in Figure 1 . This environmental lead flow scheme permits one to determine some of the environmental media that may need to be analyzed for lead given some information about the history of the locale vis-a-vis sources of lead contamination. To Sampling protocols should also reflect the physical and physicochemical characteristics of the media that are most relevant to intake and subsequent internal exposure by such risk groups as infants and toddlers. For example, soil samples of diverse particle sizes should be tested for lead only after those partide sizes within soil samples that reflect likely human intakes of soil lead are first isolated and analyzed. The smaller size soil particles, i.e., those < 150 pm, are those most likely to be ingested, most likely to be transformed in terms of lead release, most likely to have the highest relative lead content, and the fraction(s) most likely to be associated with biomarkers of exposure and of adverse effect (12) (13) (14) .
Sampling (17) . The quantification by unit area approach in subsequent investigations has been shown to be a better reflection of likely human lead exposure than the concentration-per-unit mass method (18) .
Measurable Biomarkers of Human Lead Exposure
The NRC (19, 20) defines a biologic marker of exposure as an exogenous substance or its metabolite (in some testable biological medium) or the product of an interaction between some xenobiotic agent and some target molecule or cell. There are also biomarkers of lead effect and of lead susceptibility, but these are outside the interests of this paper. Figure 2 depicts two types of lead exposure biomarkers: physiologic fluids such as whole blood (PbB) or plasma lead (PbP), and mineral tissue markers (lead in bone [PbBone] and teeth [PbT] ). PbB has been and remains the most popular biomarker. It is also the one that is both readily understood as to methodology and for which generally accepted dose-response relationships exist in terms of PbB thresholds associated with adverse effects. This dose-response relationship is depicted in Figure 3 as an analogy to a thermometer, as depicted by Mushak (21) and as adapted from the Agency for Toxic Substances and Disease Registry (ATSDR) (22) . The amount of body lead burden determines the reading in the form of the number of effects whose thresholds have been crossed. Analogous depictions have been reported (23) . Figure  3 shows thresholds in PbB for the full spectrum of adverse health effects in infants and toddlers. At Although overall PbB may show a declining slope relationship at high intakes, the overall direction of PbB is still upward. The fractional distribution of total PbB to plasma increases with a PbB increase above 50 to 60 pg/dl (35, 36) . Because this is the point along the PbB versus lead intake curve where change in slope also occurs, the nature of the curve at high intakes may be reflecting more efficient removal of circulating lead through plasma. This would indicate that tissues continue to receive a relatively linear lead load through plasma. This, in fact, appears to occur. Relative linearity in tissue lead increase with intake is seen when one compares dosing lead levels with selected tissue lead levels for rodents (37) or dogs (38) . Increased urinary lead output may occur as well with increasing intake, but its magnitude is not enough to void the linearity of the tissue lead-lead intake relationship, or the upward curvilinearity of the PbP versus increasing lead intake relationship.
The relative accuracy of PbB measurements on an individual or population group basis is determined by a host of factors. It is imperative to comprehend the impact of these factors on PbB data before one can use such information to draw conclusions about the extent of lead exposure in a community or to evaluate (validate and calibrgte) lead exposure prediction models. These factors include a) the nature of the PbB gathering process with respect to existence or absence of any programmatic infrastructure, b) the biokinetic nature of the PbB measurement itself and how it's affected by the type of PbB survey; and c) the quality of the epidemiologic and biostatistical design employed for carrying out the PbB survey program.
A critical factor in blood lead measurements is the nature of the PbB data gathering. PbB screening within a programmatic public health framework and including serial testing, i.e., PbB monitoring, has a number of advantages over a "single-shot" testing effort specifically looking at a particular community's lead exposure sources Finally, there is the problem of appropriate study design for these ad hoc, single surveys of lead-exposed communities. A number of such recent surveys done for a single community were done using study designs that pose considerable uncertainty as to identification of the most highly exposed risk population segments and the relationship of that study group's exposure to particular sources and pathways of lead exposure, e.g., exposures to extractive industry wastes. Little standardization of study designs in these lead-exposed communities has been done. Different researchers studying the same community can arrive at quite different results, depending on the nature of the study design. A (49) . In some of the older single-shot studies of lead exposure, particularly those reported in the 1 970s or earlier, the quality of the study design and methods employed were highly questionable and resulting data should be considered suspect (12) .
The overall problems with assessment of reported single-shot surveys over the years for lead-exposed communities extend to reviews of such data. The review of Danse et al. (50) concluded that lead in mill tailings at many thousands of parts per million in and around extractive-industry communities do not pose any lead exposure threats to children living there. This conclusion was based on an evaluation of historical data that was based on superficial assessments of these data, including neglect of the many nuances and complexities of these datasets. A number of the same studies and study sites were also evaluated in a 1991 critical review by Mushak (12) , and the interested reader should consult this paper. In particular, the communities referred to by Danse et (24) .
Although PbBone is also a lead accumulating marker with potential use in assessing long-term subject exposure, this marker is only now being explored as a biomarker of environmental lead exposure in children (55, 56) . This measure typically involves X-ray fluorescence (XRF) via in vivo measurements using either K or L Xrays. The different X-ray approaches appear to probe different portions of the bone compartments for lead. Bone XRF for lead has been in the research stage methodologically and interpretively with reference to general population lead exposures, but is being applied to some groups with exposure histories in childhood. Farther along is use of XRF spectrometry in assessing long-term occupational lead exposure (24, 28, (57) (58) (59) There are a number of general host and external factors that govern lead bioavailability in human populations, and especially preschool children (1, 4, 5, 12, 16, (24) (25) (26) (27) .
Infants and older children absorb lead at a higher rate than do adults in terms of lead uptake rate and in terms of intake and uptake per unit body measure, e.g., body mass or body surface area. In addition, preschoolers, especially older infants and toddlers, readily explore their environment orally, i.e., they ingest lead-contaminated materials via hand contamination and mouthing their fingers and/or direct ingestion of dusts, soils, or other contaminated materials. An extreme form of this behavior is pica, and pica for soil is called geophagia. These behavioral and developmental physiologic characteristics have been the subject of various studies over the last several decades.
Studies with human infants show that lead uptake from infant diets is on the order of 50% (63, 64) . A small group of mixed-age children studied by Alexander et al. (65) indicate that similar lead uptake rates may persist to later years, but the small Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998 sample size and the wide age spread (to 8 years of age) makes this figure tenuous for older children. Human adults typically absorb lead from ordinary diets in the amount of 10 to 15% of the dietary lead intake. With fasting conditions, adults can show higher uptake rates, paralleling those of infants at -50% or higher. This demonstrates that intrinsic gut changes can be less a factor than presence or absence of dietary factors and their interaction with lead, e.g., the lead-calcium interaction (66) (67) (68) (69) .
Experimental animal studies generally support a much higher uptake of lead in the very young child compared to adults, and these studies are critical to the development and use of animal models of lead bioavailability for infants and toddlers. Studies with nursing rodents indicate that uptake rates are quite high compared to adults or juveniles (70) (71) (72) . At weaning, however, lead uptake and retention rates abruptly and steeply decline to those of the adult. The infant monkey (73) absorbs much more lead, about 50%, than does the juvenile or adult monkey (74) . Kierski (75) showed that the weanling rabbit, 5 weeks old, absorbs twice as much lead from ingested soil as does the older rabbit. The juvenile swine, interestingly, may be farther along developmentally than the human infant but still appears to absorb lead at relatively high rates from dosed animal feeds or diet augmented with various leaded soils (76) (77) (78) (79) (80) (81) (82) .
Persistence of the elevated lead uptake rate through early childhood is still the subject of some uncertainty. Infants up to 24 months old absorb lead at about 50% of intake. There is little conclusive evidence that human infants aging to toddlers of 2 Mahaffey et al. (86) reported preliminary data suggesting that lead uptake rate in 6-year-old children approaches the adult value. These findings are based on only a few subjects, however, and require further research. In overview, if we assume that attenuation of lead uptake in the child's gut is underway after about 4 years of age, and reduced uptake is quite discernible in 6-year-old children, then the older child of 7 and 8 years of age probably resembles the adult with regard to any intrinsic versus dietary differences in lead absorption via the gut.
Approaches to Childhood Lead Bioavailability from Other Media
Although lead uptake rates from diet and water in the preschool child are assumed to be greater than for the adult under the conditions indicated above, there is growing interest in the extent of lead uptake, i.e., bioavailability, from other media, such as those generated through various industrial or waste disposal practices. This is especially so where such media exposures occur as part of various litigatory and regulatory actions dictated by Superfund and related statutory requirements. Uptake of lead from such media also are at issue in modeling lead exposure at sites, especially modeling with the U.S. EPA IEUBK model.
Bioavailability of lead in various media
can be quantified in two ways, as absolute bioavailability or relative bioavailability.
Absolute bioavailability is typically determined as the percent or fractional uptake of lead from some ingested medium relative to an injected dose, both being quantitated typically by area-under-the-curve (AUC) techniques (62) . The injected dose is assumed to represent 100% uptake. Relative bioavailability is taken as the ratio of lead uptake from some ingested medium relative to a reference ingested dose of a soluble lead salt, typically the acetate, unaffected by containment in some formulary or geochemical matrix (12, 62 Rodents and rabbits evolved to process plant material and this requires continuous feeding as a behavior to sustain microbiotic processing of cellulosic material (62) . This constant feeding behavior also can sustain a different pH than basal levels in the young child (12) . Gastric anatomy in the rodent and rabbit matches the feeding behavior and the processing of a cellulose diet, and differs greatly from that in other animal species and the human child in terms of anatomical configuration and the density of gastric acid-secreting cells. In the rodent, Weis and LaVelle (62) noted that there is a very small proportional stomach surface area associated with acid secretion when compared to the human stomach. Lead uptake occurs in certain segments of the small intestine (12) . The relative efficiency of the gut in various animal species to absorb lead, compared to a measure of potential lead intake rate such as body surface area, would be a useful predictor for enteric lead uptake rates (61, 89) . Weis and LaVelle (62) showed a much greater ratio of gut absorptive surface to body surface area for the human than for the rat. This value is 108 for humans, compared to 22 in the rat, about one-fifth the ratio. This indicates that the relative efficiency of lead uptake is 5-fold higher in humans than in rats.
Rats and rabbits engage in coprophagy, ingestion of feces, which can alter bioavailability in several ways. Such recycling means multipass uptake opportunities on one hand, but also microbiotically transformed fecal material that may bind lead differently on the other. One can use fasted rats and rabbits to attempt to minimize the constant feeding. Coprophagy can be difficult to control even if appropriate cages are used.
Rodents and rabbits, as poor animal models for infant and toddler lead bioavailability, would be expected to show lower absolute and relative lead bioavailability than would be expected for the same material in the human infant and toddler.
Infants and toddlers get their principal nourishment via their major meals at intermittent or scheduled feedings by their caregivers, have a greatly different gastric physiology and anatomy than the rodent and the rat, and have other differences noted above (12, 62, 90 Use of a certain animal species for quantifying lead bioavailability does not assure a particular result. The variability and uncertainties in lead uptake in soil lead-dosed rodents can be seen in differing results from three different reports of soil surface-bound lead (rather than lead occurring within the soil particle matrix itself in some geochemical form). Lead bound to soil surfaces would simulate the very common child lead exposure scenario of lead fallout from atmospheric lead emissions from some industrial source coming into contact with nearby residential surface soils. Freeman et al. (93) found that bioavailability of lead from lead acetate without control soil in diet was significantly higher than when control soil was present, indicating a soil suppression of uptake. Lead sulfide, however, showed no such reduction with soil present. Sheppard and co-workers (94) found that use of radiolabeled soluble lead salt (nitrate) added to feed with and without added soil (5 or 20% soil by feed weight) showed no statistically significant effect of this diet soil loading on lead uptake in mice fed for 30 days with radiolabeled lead in soil-dosed feed mix.
The authors were careful to note that carcass total label and label concentrations decreased as soil fraction increased, but this was due to intake differences of the mixed feed. When the radiolabeled content was normalized for intake differences, no statistically significant effect of soil on lead label uptake was seen. Absence of an effect of soil on lead uptake was reported by Dacre and Ter Haar (87) in an earlier study of lead-in-soil bioavailability using adult rats. Soils fed for 30 or 90 days and that contained lead associated with either atmospheric fallout onto soil from auto exhaust lead or paint lead deposition were compared to equivalent diet loading with lead acetate without soil. PbB levels among the three groups were statistically indistinguishable at 30 days; at 90 days, PbB for the soluble lead group was not given, but the remaining two 90-day groups were not statistically distinguishable.
Lead incorporated into geochemical matrices has been reported to have lower bioavailability when added to diet of rats, compared to acetate and other relatively simple lead species (91, 95, 96) . In the study of Dieter et al. (96) , using 6-to 7-week-old rats, the geochemical lead was contained in recently generated Alaskan ore concentrate. Comparison lead species were the acetate, oxide, and sulfide. At a diet dosing of 100 ppm lead in all forms, the lead ore PbB group was about 10% that of the lead acetate group. Lead sulfide also had less bioavailability than the acetate and oxide. Freeman and co-workers (91, 93, 95) studied soil lead bioavailability in variably aged rats, with the lead-containing materials including mining wastes. Both absolute bioavailability (95) and relative bioavailability, as a ratio with soluble lead acetate reference (91), were tested, and were much lower in soil-entrained lead than when soluble lead salt was used. The absolute bioavailability of lead salt indexed as PbB was reported (95) as about 6-fold higher than soil-encased lead-15% versus 2.7%.
Freeman et al. (93) also reported that residential soil-encased lead from a Colorado extractive industry-impacted community showed significantly less bioavailability than soluble lead as the acetate salt.
Several studies have described the use of rabbits in assessing lead bioavailability from mining waste samples, despite the considerable caveats about this species' use in such investigations. The reports of Ruby et al. (97) and Davis et al. (98) describe feeding studies using 3-monthold New Zealand white rabbits and mining waste material acutely administered as a large, single bolus. Ruby et al. (96) included time-serial PbB measurements and the lead content of various GI tract fractions isolated over time, with the animals being dosed to provide information on bioaccessibility, a recently coined term for extent of lead solubilization from some medium into human or animal gastric fluid, or simulations thereof. This term has not yet been generally accepted by the toxicology community nor fully characterized as to validity. The term provides no direct measure of bioavailability, but is linked to it. Ruby et al. (97) reported that the measured soluble fraction of mine waste bolus lead in rabbit GI tract is markedly lower than that for lead given as the acetate salt. This study has been widely cited by the authors and others as a reliable animal model of lead bioavailability from extractive-industry wastes and it is important that the study be examined carefully and in some detail.
There are quite a few technical and interpretive problems with Ruby et al. (97) that greatly limit applicability of their results for bioavailability conclusions applicable to humans. This report does provide information consistent with the broad experimental caveat that rabbits are poor animal models of lead bioavailability in preschool children and poor animal calibrators for subsequent in vitro screening of geochemical lead media. Flaws include incomplete and incorrect time-point studies of lead uptake, mine waste groups being tested differently than the lead acetate group, and both being evaluated as isolated lead concentration points and as concentration ratios to the reference data point, rather than use of the preferred, universally employed technique of AUC measurements. The AUC method would be required because lead uptake to blood from the mine waste material was rising significantly throughout the testing time (36 hr) and likely beyond it. At the end of 36 hr, waste material-dosed rabbits showed PbB content 4-fold higher than at 1 hr, the sole testing point for the reference acetate dose. These authors used these incorrectly obtained ratios to calculate in vivo solubilization of lead in the rabbit gut and from these estimates, proportional bioavailability as well. One cannot retrospectively attempt AUC calculations with these published data and reestimate solubilization and relative uptake, as only one data point, at 1 hr, exists for the critical acetate reference group.
Additional areas of testing and interpretation difficulty with Ruby et al. (97) include a) a mass balance analysis carried out by the present author that showed that much of the starting lead dose administered to the various groups cannot be accounted for by any biokinetically likely means, b) unacceptably low solubility of lead acetate in the stomach of these rabbits, and c) use of a swamping bolus of lead-containing material that is qualitatively and quantitatively irrelevant to typical children's soil/dust ingestion behaviors.
The present author's mass balance analysis for lead in the Ruby et al. (96) rabbit study, using Table III of Ruby et al., showed that the fraction of starting lead dose appearing in rabbit GI tract contents, i.e., soluble and solid fractions of lumen contents, summed over stomach, small intestine, and large intestine, is significantly less than the dosing level, and the shortfall occurs over the 6 hr of complete necropsy-group testing. At 3 hr, 60%, and at 6 hr, 91% of the 16.4-mg starting dose cannot be accounted for in collected GI tract contents. These declines occur with increases in total PbB content. The 1-hr time point for lead acetate shows 60% unaccounted for. Over these short time points, lead loss via fecal excretion would not account for the shortfall. It is plausible that only partial collection of GI tract contents occurred or that much of the missing lead had been transported to intestinal mucosa epithelium. If the latter, the resulting high ratio of enteric tissue lead to reported PbB would be extremely high, relative to what one typically sees in such distribution data. The time course of lead uptake in these rabbits was apparently far from complete, and would likely produce a much higher estimate of lead bioavailability with a longer testing time frame. Ruby et al. (97) did not analyze GI tract tissue, nor internal organs including bone, for lead levels. Deposition of the missing lead in internal organs would show uptake, but would arguably require higher PbB content than that reported by these authors. (97) shows only 37% solubility for the soluble lead species employed, the acetate salt. This percentage is half that for the companion in vitro simulation and about onethird of expected 100% solubility. The authors suggest lead binding to retained animal chow, but the data in their Figure  2 do not support this assumption.
Finally, the Ruby et al. (97) study uses a mass of matrix, 4.2 g (2-g lead sample/kg, Environmental Health Perspectives * Vol 106, Supplement 6 * December 1998 2.1 kg weight) given as a single dose, a route of dosing that is totally inappropriate for any comparisons with childhood daily ingestion rates, as described in a later section. Although Ruby et al. based this administration rate on a 10-g soil intake in a pica child, this quantity for a pica child is itself quite suspect. Furthermore, the typical child engaging in mouthing activity is only ingesting 100 to 200 mg soil/dust, and doing so over the entire play period as noted later.
The above reanalysis indicates that lead uptake from the mining waste materials in the rabbits used in Ruby et al. may have been more than their reported data would indicate. In addition, use of the rabbit model by Ruby et al. (97) for calibrating an in vitro approach also described in that paper is untenable for application to child lead bioavailability from these materials.
Kierski (75) showed that soil Pb is relatively less bioavailable than lead acetate in 5-week-old rabbits when large amounts of soil are given, but when soil quantities more relevant to child intakes are used, the relative absorption increased to 55 (71) recorded lead uptake rate versus rat pup age at multiple time points and showed that rats are close to the adult uptake rate several days after weaning. This means that use of rats about 26 days or older results in adult lead uptake data. Kierski (75) showed that 5-week-old weanlings had higher lead uptake than older rabbits.
The bioavailability studies of Freeman et al. (91, 93, 95) Young swine used in the studies described above (90) were at the juvenile stage, 5 to 6 weeks old. In swine, weaning occurs at about 3 weeks. The somatic maturation process in the swine is much slower (62) and puberty is reached much later on the absolute time scale than in rats. This may include physiologic maturation of the GI tract. Although the precise quantitative relationship of young swine development to enteric lead uptake has not been determined, we expect that the lead uptake rates in those weanling swine studied so far would be greater than the adult uptake rates Freeman et al. encountered for lead bioavailability. With rabbits, Ruby et al. (97) were using postweanling animals with reduced lead uptake compared to rabbits at 5 weeks or younger as studied by Kierski (75) .
Child Mindful of these caveats, several investigators have attempted to provide a closer simulation of in vivo lead uptake processes for screening purposes by focusing on one parameter, simulated solubilization in the stomach and retention of the solubilized fraction during passage through portions of the small intestine where lead is known to be absorbed (12 This paper presents the uses and limits of empirical data in the evaluation of predictive models of human lead exposure, mainly biokinetic or mechanistic models. These models generate PbB estimates that offer the risk assessor or risk manager assistance in evaluating the nature and extent of lead's potential adverse impacts in exposed communities. A particular focus was the U.S. EPA IEUBK biokinetic model, used to estimate childhood lead exposure. This model is the most heavily validated and calibrated of the several biokinetic models now of interest in the lead risk assessment community. These models, when used correctly with appropriate empirical data inputs, additionally possess the flexibility to a) ascertain historic exposures via dose reconstruction from current environmental data, b) estimate results of some regulatory intervention, e.g., predicted PbB responses to soil lead abatement, and c) ascertain the consequences of future land use options in and around a lead-contaminated site, in terms of resulting PbB concentrations.
This paper points out, with supporting information, that one must be very careful in the use of measurement data for either evaluating or challenging the outputs, i.e., exposure estimates, of such predictive models. A number of specific points were made about potential pitfalls in the use of PbB levels either separate from or in tandem with modeling efforts. The paper noted various criteria that define more reliable forms of PbB data, for use in assessment and modeling community lead exposures: a) the use of serial versus single-shot PbB measurements; and, where serial measures are not feasible, b) the absence of temporal and structural artifacts that would reduce the reliability of PbB data, confounders that include public awareness and concerns of child caregivers that result in abrupt, transitory reduction in PbB; c) use of an appropriate biostatistical and epidemiologic design that does not obscure the prevalence of toxic lead exposures in those segments of the study population at particular risk; and d) PbB data that provide reliable and accurate links to those environmental lead sources that produce the significant lead exposures.
Predictive, biokinetic models of lead exposure in high-risk groups rarely come equipped with all the best selections for inputs and outputs for a particular site and require a certain level of site-specific information. One significant biokinetic component of any lead model input is the lead uptake rate or bioavailability, especially in the GI tract. This paper provides a fairly detailed discussion of bioavailability, a growing but often misunderstood or misused topic in the lead area. Discussion includes various approaches for determining this parameter in clean, physiologic terms, i.e., experimental animal models of lead bioavailability in human infants and toddlers. Such models avoid many of the problems of looking at human populations directly. The article shows that rodents and rabbits are not particularly good models of lead uptake in the infant and toddler, especially under conditions actually reported in published work. Published work using rats and rabbits produced data that are problematic on added grounds. Lead-dosing methods included those that have little relevance to typical childhood oral lead exposures. To Finally, lead bioavailability has to be put into quantitative toxicologic context. That is, one cannot equate lead bioavailability to a specific net toxic risk in isolation. This is simply because the total amount of lead entering the bloodstream from the GI tract per unit time is the product of bioavailability multiplied by lead concentration in some ingested substance. An intrinsic bioavailability of 100% for a lead species that is not present in the exposure medium does not result in lead poisoning or risk of lead poisoning. For media with variable lead content and in different geochemical/formulary forms, comparisons must be more closely drawn. A bioavailability of 10% for a lead species occurring at a concentration of 2000 ppm in 100 mg of ingested matrix is no less toxic than a lead species that is 100% bioavailable from 100 mg of a matrix having 200 ppm lead. Lead at an extremely low bioavailability of 1% is equally toxic under the above conditions at a lead concentration of 20,000 ppm.
There has been a simplistic tendency in some regulatory areas and the recent risk assessment literature to confuse comparative statements of lead bioavailability with net toxicologic rankings. For example, mining waste lead is held by some to always be less bioavailable than lead from urban street dust. That is partly true, and in certain situations. That is not equivalent to saying that mining waste is not toxic to children. It also does not say that there are no risks to children who come in contact with this material. The above trio of bioavailability comparisons voids this premise. The fallacy of the assumption can be understood when we consider that ore mill tailings and weathering smelter slags can contain lead at many thousands of parts per million. Children ingesting 100 to 200 mg of such material with 20,000 ppm lead and a low lead form bioavailability of 5% are still at high risk for lead poisoning.
